Well, that’s two of you that reckon CYP will commercialise after the FDA P2. Makes you wonder why they bothered starting the Turkey P2 for GVHD, doesn’t it?
Maybe they will commercialise after both P2’s for GVHD? Wouldn’t that be something?
Got your Oz lotto numbers in?
Ann: First Patient Treated in Phase 2 GvHD Trial, page-13
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.15M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.5¢ | 16.0¢ | $62.06K | 386.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 70000 | 2 |
View Market Depth
| Last trade - 14.47pm 25/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |